A Barrios*, A Rendón, P Ríos, L Martín-Carbonero, D González de Requena, O Gallego, L Valer, I Maida, I Jimenez-Nacher, J Gonzalez-Lahoz, and V Soriano
Hosp. Carlos III, Madrid, Spain
M Boffito*1, M Kurowski2, G Kruse2, A Hill3, M Nelson1, G Moyle1, A Benzie1, C Higgs1, C Fletcher1, I Hitchcock4, B Gazzard1, and A Pozniak1
1Chelsea and Westminster Hosp., London, UK; 2Therapia GmbH, Berlin, Germany; 3Roche, Welwyn, UK; and 4Bristol-Myers Squibb Co., London, UK
M Boffito*1, L Dickinson2, A Hill3, M Nelson1, G Moyle1, C Higgs1, C Fletcher1, S Mandalia1, D Back2, B Gazzard1, and A Pozniak1
1Chelsea and Westminster Hosp., London, UK; 2Univ. of Liverpool, UK; and 3Roche, Welwyn, UK
H E Wynn Vezina*1, R C Brundage1, L Bushman2, and C V Fletcher2
1Univ. of Minnesota, Minneapolis, USA and 2Univ. of Colorado Hlth. Sci. Ctr., Denver, USA
D González de Requena*, T García-Benayas, O Gallego, F Blanco, L Valer, I Jimenez-Nacher, A L Rendón, and V Soriano
Hosp. Carlos III, Inst. de Salud Carlos III, Madrid, Spain
A H Corbett*1, L Davidson1, J J Park1, K Patterson1, J J Eron1, L Ngo1, M L Lim2, M Shelton2, M B Wire2, and A D M Kashuba1
1Chapel Hill, NC, USA and 2Res. Triangle Park, NC, USA
M B Wire*1, O J Naderer1, A L Masterman2, Y Lou1, and D S Stein1
1GlaxoSmithKline, Research Triangle Park, NC, USA and 2GlaxoSmithKline, Montreal, Quebec, Canada
B Best*1, S May1, M Witt2, C Kemper3, R Larsen4, C Diamond5, P Heseltine6, F He1, E Capparelli1, A McCutchan1, R Haubrich1, and the California Collaborative Treatment Group (CCTG)
1Univ. of California, San Diego, USA; 2Harbor-UCLA Med. Ctr., Univ. of California, Los Angeles Sch. of Med., Torrance, CA, USA; 3Santa Clara Valley Med. Ctr., San Jose, CA, USA; 4Univ. of Southern California, Los Angeles, USA; 5Univ. of California, Irvine, USA; and 6Quest Diagnostics, San Juan Capistrano, CA, USA
G D Morse*1, S Rosenkranz2, M F Para3, E Adams4, K E Yarasheski5, R C Reichman6, and Adult AIDS Clinical Trials Group (AACTG); DAIDS, NIAID, NIH; Bethesda, MD, USA
1State Univ. of New York at Buffalo, USA; 2Harvard Sch. of Publ. Hlth., Boston, MA, USA; 3Ohio State Univ., Columbus USA; 4DAIDS, NIAID, NIH, DHHS, Bethesda, MD, USA; 5Washington Univ., St. Louis, MO, USA; and 6Univ. of Rochester, NY, USA
C Zala*1, C S Alexander2, C Ochoa 1, S Guillemi2, L S Ting2, J J Asselin2, P Cahn1, and J S G Montaner2
1Fndn. Huesped, Buenos Aires, Argentina and 2British Columbia Ctr. for Excellence in HIV/AIDS, Vancouver, Canada
M Boyd*1,2, D Burger3, P Mootsikapun4, T Chuenyam1, S Ubolyam1, J Sangkote1, P Bunyaprawit4, M Horsakulchai4, J Lange1,5, D Cooper1,2, P Phanupak1,6, and K Ruxrungtham1,6
1The HIV Netherlands Australia Thailand Res. Collaboration (HIVNAT), Thai Red Cross AIDS Res. Ctr. Bangkok, Thailand; 2Natl. Ctr. in HIV Epidemiology and Clin. Res., Univ. of New South Wales, Sydney, Australia; 3Univ. Med. Ctr. Nijmegen, The Netherlands; 4Srinagarind Hosp., Faculty of Med., Khon Kaen Univ., Thailand; 5Acad. Med. Ctr., Amsterdam, The Netherlands; and 6Chulalongkorn Univ. Faculty of Med., Bangkok, Thailand
T Hulgan*, J Donahue, R Kim, C Sutcliffe, B Lishawa, F Nicotera, R D'Aquila, and D Haas
Vanderbilt Univ., Nashville, TN, USA
B Chandler*, A Owen, D Back, and S Khoo
Univ. of Liverpool, UK
P L Anderson*1, J Lamba1,2, E Schuetz2, and C V Fletcher1,2
1Univ. of Colorado Hlth. Sci. Ctr., Denver, USA and 2St. Jude Children’s Res. Hosp., Memphis, TN, USA
A Owen*1, Z Fox2, L Almond1, U Bak Dragsted3, D Back1, M Youle4, J Lundgren3, S Khoo1, and The MaxCmin1 Steering Comittee
1Liverpool Univ., UK; 2Royal Free and Univ. Coll. Med. Sch., London, UK; 3Hvidovre Univ. Hosp., Hvidovre, Denmark; and 4Royal Free Hosp., London, UK
